Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (3): 420-424. doi: 10.19723/j.issn.1671-167X.2020.03.004

Previous Articles     Next Articles

Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes

Hang YANG1,Lin-cheng YANG2,Rui-tao ZHANG2,Yun-peng LING1,△(),Qing-gang GE3,△()   

  1. 1. Department of Cardiac Surgery
    2. Department of Cardiology
    3. Department of Intensive Care Unit, Peking University Third Hospital, Beijing 100191, China
  • Received:2020-04-13 Online:2020-06-18 Published:2020-06-30
  • Contact: Yun-peng LING,Qing-gang GE E-mail:micsling@163.com;qingganggelin@126.com

RICH HTML

 51   

PDF (PC)

448

Abstract:

Objective: The pathogenesis of myocardial injury upon corona virus disease 2019 (COVID-19) infection remain unknown,evidence of impact on outcome is insufficient, therefore, we aim to investigate the risk factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes in this study.Methods: This was a single-centered, retrospective, observational study. Patients of Sino-French Eco-City section of Tongji Hospital, Wuhan, China attended by Peking University Supporting Medical Team and admitted from Jan. 29, 2020 to Mar. 20, 2020 were included. The positive nucleic acid of COVID-19 virus and combination with hypertension, coronary heart disease or diabetes were in the standard. We collected the clinical data and laboratory examination results of the eligible patients to evaluate the related factors of death.Results: In the study, 94 COVID-19 patients enrolled were divided into the group of death (13 cases) and the group of survivors (81 cases), the average age was 66.7 years. Compared with the survival group, the death group had faster basal heart rate(103.2 beats/min vs. 88.4 beats /min, P=0.004), shortness of breath(29.0 beats /min vs. 20.0 beats /min, P<0.001), higher neutrophil count(9.2×109/L vs. 3.8×109/L, P<0.001), lower lymphocyte count(0.5×109/L vs. 1.1×109/L, P<0.001), creatine kinase MB(CK-MB, 3.2 μg/L vs. 0.8 μg/L, P<0.001), high sensitivity cardiac troponin Ⅰ(hs-cTnⅠ, 217.2 ng/L vs. 4.9 ng/L, P<0.001), N-terminal pro brain natriuretic peptide(NT-proBNP; 945.0 μg/L vs. 154.0 μg/L, P<0.001), inflammatory factor ferritin(770.2 μg/L vs. 622.8 μg/L , P=0.050), interleukin-2 recepter(IL-2R, 1 586.0 U/mL vs. 694.0 U/mL, P<0.001), interleukin-6(IL-6, 82.3 ng/L vs. 13.0 ng/L, P<0.001), interleukin-10(IL-10, 9.8 ng/L vs. 5.0 ng/L, P<0.001)were higher than those in the survival group. Univariate logistic regression analysis showed that the risk factors for death were old age, low non oxygen saturation, low lymphocyte count, myocardial injury, abnormal increase of IL 2R, IL-6, and IL-10. Multivariate regression showed that old age (OR=1.11, 95%CI=1.03-1.19, P=0.026), low non oxygen saturation(OR=0.85, 95%CI=0.72-0.99, P=0.041), and abnormal increase of IL-10(>9.1 ng/L, OR=101.93, 95%CI=4.74-2190.71, P=0.003)were independent risk factors for COVID-19 patients combined with hypertension, coronary heart disease or diabetes.Conclusion: In COVID-19 patients combined with hypertension, coronary heart disease or diabetes, the risk factors for death were old age, low non oxygen saturation, low lymphocyte count, myocardial injury, and abnormal increase of IL-2R, IL-6, and IL-10. Old age, low non oxygen saturation and abnormal increase of IL-10 were independent risk factors.

Key words: COVID-19, Hypertension, Coronary heart disease, Diabetes, Risk factors

CLC Number: 

  • R563.1

Table 1

Distribution of COVID-19 patients combined with hypertension, coronary heart disease or diabetes"

Items Death group
(n=13)		 Survival group
(n=81)
Hypertension 7 47
Diabetes 2 3
CHD 0 6
Hypertension & diabetes 1 13
Hypertension & CHD 1 4
Diabetes & CHD 1 1
Hypertension & diabetes & CHD 1 7

Table 2

Demographic and baseline informations"

Items Death group(n=13) Survival group(n=81) t/Z/χ2 P
General information
Age/years, M(IQR) 77.0 (67.5, 83.0) 66.0 (59.0, 72.5) -2.894 0.731
Male, n(%) 8 (61.5) 37 (45.7) 1.129 0.288
Vital signs on admission
Heart rate/(beats/min), x?±s 103.2±15.8 88.4±16.7 2.997 0.004
Systolic pressure/mmHg, M(IQR) 135.0 (109.0, 161.5) 140.0 (125.0, 149.5) -0.526 0.599
Diastolic pressure (mmHg), x?±s 84.6±15.7 84.0±13.1 0.156 0.876
Respiratory rate/(beats/min), M(IQR) 29.0 (24.0, 30.0) 20.0 (20.0, 24.0) -3.689 <0.001
SpO2/%, M(IQR) 89.0 (78.5, 94.5) 96.0 (94.0, 98.0) -3.232 1.000
Complete blood count
WBC (×109/L), M(IQR) 10.2 (6.3, 14.7) 5.6 (4.5, 7.8) -3.242 1.000
Neutrophil (×109/L), M(IQR) 9.2 (5.5, 13.9) 3.8 (2.7, 5.9) -3.510 <0.001
Lymphocyte (×109/L), M(IQR) 0.5 (0.3, 0.7) 1.1 (0.7, 1.5) -3.719 <0.001
Creatinine/(μmol/L), M(IQR) 86.0 (73.5, 112.5) 74.0 (57.0, 92.0) -1.807 0.073
Biomarkers of myocardial injury
CK-MB/(μg/L), M(IQR) 3.2 (2.3, 6.9) 0.8 (0.5, 1.0) -4.196 <0.001
hs-cTNⅠ/(ng/L), M(IQR) 217.2 (34.4, 4037.4) 4.9 (2.5, 13.9) -4.513 <0.001
NT-proBNP/(μg/L), M(IQR) 945.0 (518.5, 3 464.0) 154.0 (75.0, 415.3) -4.111 <0.001
Myocardial injury, n(%) 10 (76.9) 13 (16.0) 22.461 <0.001
Cytokines
Ferritin/(μg/L), M(IQR) 770.2 (598.0, 2 172.0) 622.8 (385.3, 1 162.7) -2.180 0.050
IL-2R/(U/mL), M(IQR) 1 586.0 (1 253.0, 2 364.0) 694.0 (425.0, 1 054.5) -3.740 <0.001
IL-6/(ng/L), M(IQR) 82.3 (37.8, 164.8) 13.0 (4.0, 39.4) -3.960 <0.001
IL-8/(ng/L), M(IQR) 29.1 (16.2, 52.4) 12.4 (7.0, 21.3) -2.551 0.160
IL-10/(ng/L), M(IQR) 9.8 (6.8, 17.9) 5.0 (5.0, 5.5) -4.376 <0.001
TNF-α/(ng/L), M(IQR) 13.3 (7.2, 17.4) 8.8 (5.7, 12.3) -2.202 0.051

Table 3

Logistic regression analysis of factors of death"

Items Univariate analysis Multivariate analysis
OR(95%CI) P OR(95%CI) P
Age/years 1.11 (1.03, 1.19) 0.004 1.18 (1.02, 1.36) 0.026
Male 1.90 (0.57, 6.32) 0.293 0.16 (0.02, 1.55) 0.113
Hypertension (No vs. Yes) 0.47 (0.11, 2.00) 0.307
Diabetes (No vs. Yes) 1.48 (0.44, 5.00) 0.524
CHD (No vs. Yes) 1.05 (0.26, 4.23) 0.945
SpO2/% 0.89 (0.83, 0.96) 0.001 0.85 (0.72, 0.99) 0.041
Neutrophil (×109/L) 1.05 (0.98, 1.11) 0.155
Lymphocyte (×109/L) 0.03 (0.00, 0.30) 0.003
Creatinine/(μmol/L) 1.00 (0.99, 1.01) 0.897
Myocardial injury 17.44 (4.21, 72.1) <0.001 11.77 (0.93, 148.87) 0.057
Ferritin>400 μg/L 5.36 (0.66, 43.48) 0.116
IL-2R>710 U/mL 5.64 (1.18, 27.05) 0.031
IL-6>35 ng/L 8.40 (2.12, 33.33) 0.002
IL-8>62 ng/L 4.73 (0.71, 31.52) 0.109
IL-10>9.1 ng/L 14.60 (3.84, 55.46) <0.001 101.93 (4.74, 2 190.71) 0.003
TNF-α>8.1 ng/L 1.71 (0.49, 6.02) 0.402
[1] Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci, 2020,63(3):457-460.
pmid: 32009228
[2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10223):497-506.
doi: 10.1016/S0140-6736(20)30183-5 pmid: 31986264
[3] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020,395(10229):1054-1062.
pmid: 32171076
[4] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 2(2020-02-07)[2020-04-06]. https://jamanetwork.com/journals/jama/fullarticle/2761044.
[5] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018)[J]. J Am Coll Cardiol, 2018,72(18):2231-2264.
[6] Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)[J]. Thorax, 2003,58(8):686-689.
pmid: 12885985
[7] Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area[J]. JAMA, 2003,289(21):2801-2809.
pmid: 12734147
[8] Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis[J]. Int J Infect Dis, 2016,49:129-133.
[9] Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020,181(2):271-280.
doi: 10.1016/j.cell.2020.02.052 pmid: 32142651
[10] Hamming I, Timens W, Bulthuis M, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]. J Pathol, 2004,203(2):631-637.
[11] Keidar S, Kaplan M, Gamliellazarovich A, et al. ACE2 of the heart: From angiotensin Ⅰ to angiotensin (1-7)[J]. Cardiovasc Res, 2007,73(3):463-469
pmid: 17049503
[12] Clerkin KJ, Fried JA, Raikhelkar J, et al. Corona virus disease 2019 (COVID-19) and cardiovascular disease[J]. Circulation, 2020, 3(2020-03-21)[2020-04-07]. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.046941.
[13] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of corona virus disease 2019 in China[J]. N Engl J Med, 2020,382(18):1708-1720.
[14] Hu H, Ma F, Wei X, et al. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin[J]. Eur Heart J, 2020, (2020-03-16)[2020-04-08]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184348.
pmid: 32562486
[15] Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection[J] Eur Heart J, 2020, 4(2020-04-08)[2020-04-10]. https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa286/5817735.
[16] Chen Z, Hu Y, Xiong T, et al. IL-10 promotes development of acute respiratory distress syndrome via inhibiting differentiation of bone marrow stem cells to alveolar type 2 epithelial cells[J]. Eur Rev Med Pharmacol Sci, 2018,22:6085-6092.
[17] Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology[J]. Semin Immunopathol, 2017,39(5):529-539.
[18] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
doi: 10.1016/S0140-6736(20)30211-7 pmid: 32007143
[19] Watts ER, Walmsley SR. Inflammation and Hypoxia: HIF and PHD Isoform Selectivity[J]. Trends Mol Med, 2019,25(1):33-46.
[20] Campbell EL, Bruyninckx WJ, Kelly CJ, et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation[J]. Immunity, 2014,40(1):66-77.
[1] XU Xin-ran,HUO Peng-cheng,HE Lu,MENG Huan-xin,ZHU Yun-xuan,JIN Dong-si-qi. Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 48-53.
[2] SU Jun-qi,SONG Yang,XIE Shang. Analysis of etiological characteristics and establishment of prediction model of postoperative infections in patients undergoing oral squamous cell carcinoma surgery with free flap reconstruction [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 68-76.
[3] Yun-shu XIAO,Feng-yun-zhi ZHU,Lan LUO,Xiao-yan XING,Yu-hui LI,Xue-wu ZHANG,Dan-hua SHEN. Clinical and immunological characteristics of 88 cases of overlap myositis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1088-1093.
[4] Hao XU,Guo-dong ZHANG,Guang-pu FAN,Yu CHEN. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143.
[5] Zhan-yue NIU,Yan XUE,Jing ZHANG,He-jun ZHANG,Shi-gang DING. Analysis of endoscopic and pathological features of gastric adenomatous polyps and risk factors for canceration [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1122-1127.
[6] Hong MENG,Li-na JI,Jing HUANG,Shuang CHAO,Jia-wen ZHOU,Xue-jun LI,Xiao-mei YIN,Li-rong FAN. Analysis of the changes and characteristics of pediatric outpatient visits in a general hospital in Beijing before and after the COVID-19 pandemic [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 952-956.
[7] Jing-xian ZHU,Sheng-nan LU,Yan-fang JIANG,Ling JIANG,Jian-quan WANG. Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 902-906.
[8] WANG Jia-wen,LIU Jing-chao,MENG Ling-feng,ZHANG Wei,LIU Xiao-dong,ZHANG Yao-guang. Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 653-658.
[9] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[10] WU Jun-hui,CHEN Hong-bo,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,WANG Meng-ying,WANG Si-yue,WANG Xiao-wen,WANG Jia-ting,YU Huan,HU Yong-hua. Prevalence and risk factors of osteoarthritis in patients with type 2 diabetes in Beijing, China from 2015 to 2017 [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 518-522.
[11] GUO Hong-ping,ZHAO Ai,XUE Yong,MA Liang-kun,ZHANG Yu-mei,WANG Pei-yu. Relationship between nutrients intake during pregnancy and the glycemic control effect in pregnant women with gestational diabetes mellitus [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 467-472.
[12] FAN Li-shi,GAO Min,Edwin B. FISHER,SUN Xin-ying. Factors associated with quality of life in 747 patients with type 2 diabetes in Tongzhou District and Shunyi District of Beijing [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 523-529.
[13] CHEN Ping,LI Ze-ming,GUO Yi,SUN Xin-ying,Edwin B. FISHER. To explore medication adherence of patients with type 2 diabetes mellitus using the latent profile analysis based on the Big Five personality theory [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 530-535.
[14] HUANG Bing, WANG Hong-yuan. Analysis of the development trend and severity of the COVID-19 panidemic in the global world [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 536-542.
[15] ZHOU Bo-lin,LI Wei-shi,SUN Chui-guo,QI Qiang,CHEN Zhong-qiang,ZENG Yan. Risk factors for multiple debridements of the patients with deep incisional surgical site infection after spinal surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 286-292.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd